Dysregulation of neurosteroids in obsessive compulsive disorder
Authors:
- K.L. BigosKBK.L. Bigos
- M.M. FolanMFM.M. Folan
- M.R. JonesMJM.R. Jones
- G.L. HaasGHG.L. Haas
- 1 January 2009
- journal article
- other
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 43 (4) , 442-445
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Positive correlation between anxiety severity and plasma levels of dehydroepiandrosterone sulfate in medication‐free patients experiencing a major episode of depressionPsychiatry and Clinical Neurosciences, 2006
- Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorderPsychiatry Research, 2005
- Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and β-endorphinFertility and Sterility, 2005
- Neurosteroids: Biosynthesis and Function of These Novel NeuromodulatorsFrontiers in Neuroendocrinology, 2000
- Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in miceBrain Research, 1997
- Corticotropin releasing factor stimulation test in obssesive compulsive disorderBiological Psychiatry, 1994
- Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorderPsychiatry Research, 1992
- The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptorBrain Research, 1990
- Dexamethasone Suppression Test in Patients with Primary Obsessive-Compulsive Disorder and in Healthy ControlsNeuropsychobiology, 1990
- Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: A confirmatory reportPsychiatry Research, 1984